Targeting nuclear RNA for in vivo correction of myotonic dystrophy (original) (raw)

• Harley, H. G. et al. Expansion of an unstable DNA region and phenotypic variation in myotonic dystrophy. Nature 355, 545–546 (1992)
  Article ADS CAS PubMed Google Scholar
• Buxton, J. et al. Detection of an unstable fragment of DNA specific to individuals with myotonic dystrophy. Nature 355, 547–548 (1992)
  Article ADS CAS PubMed Google Scholar
• Brook, J. D. et al. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell 68, 799–808 (1992)
  Article CAS PubMed Google Scholar
• Taneja, K. L., McCurrach, M., Schalling, M., Housman, D. & Singer, R. H. Foci of trinucleotide repeat transcripts in nuclei of myotonic dystrophy cells and tissues. J. Cell Biol. 128, 995–1002 (1995)
  Article CAS PubMed Google Scholar
• Davis, B. M., McCurrach, M. E., Taneja, K. L., Singer, R. H. & Housman, D. E. Expansion of a CUG trinucleotide repeat in the 3′ untranslated region of myotonic dystrophy protein kinase transcripts results in nuclear retention of transcripts. Proc. Natl Acad. Sci. USA 94, 7388–7393 (1997)
  Article ADS CAS PubMed PubMed Central Google Scholar
• Mankodi, A. et al. Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat. Science 289, 1769–1773 (2000)
  Article ADS CAS PubMed Google Scholar
• Bennett, C. F. & Swayze, E. E. RNA targeting therapeutics: molecular mechanisms of antisense oligonucleotides as a therapeutic platform. Annu. Rev. Pharmacol. Toxicol. 50, 259–293 (2010)
  Article CAS PubMed Google Scholar
• Geary, R. S. et al. Pharmacokinetics of a tumor necrosis factor-alpha phosphorothioate 2′-_O_-(2-methoxyethyl) modified antisense oligonucleotide: comparison across species. Drug Metab. Dispos. 31, 1419–1428 (2003)
  Article CAS PubMed Google Scholar
• Wilusz, J. E., Freier, S. M. & Spector, D. L. 3′ end processing of a long nuclear-retained noncoding RNA yields a tRNA-like cytoplasmic RNA. Cell 135, 919–932 (2008)
  Article CAS PubMed PubMed Central Google Scholar
• Lorenz, P., Misteli, T., Baker, B. F., Bennett, C. F. & Spector, D. L. Nucleocytoplasmic shuttling: a novel in vivo property of antisense phosphorothioate oligodeoxynucleotides. Nucleic Acids Res. 28, 582–592 (2000)
  Article CAS PubMed PubMed Central Google Scholar
• Vickers, T. A. et al. Efficient reduction of target RNAs by small interfering RNA and RNase H-dependent antisense agents. A comparative analysis. J. Biol. Chem. 278, 7108–7118 (2003)
  Article CAS PubMed Google Scholar
• Prasanth, K. V. et al. Regulating gene expression through RNA nuclear retention. Cell 123, 249–263 (2005)
  Article CAS PubMed Google Scholar
• Wu, H. et al. Determination of the role of the human RNase H1 in the pharmacology of DNA-like antisense drugs. J. Biol. Chem. 279, 17181–17189 (2004)
  Article CAS PubMed Google Scholar
• Suzuki, Y. et al. An upstream open reading frame and the context of the two AUG codons affect the abundance of mitochondrial and nuclear RNase H1. Mol. Cell. Biol. 30, 5123–5134 (2010)
  Article CAS PubMed PubMed Central Google Scholar
• Lin, X. et al. Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy. Hum. Mol. Genet. 15, 2087–2097 (2006)
  Article CAS PubMed Google Scholar
• Osborne, R. J. et al. Transcriptional and post-transcriptional impact of toxic RNA in myotonic dystrophy. Hum. Mol. Genet. 18, 1471–1481 (2009)
  Article CAS PubMed PubMed Central Google Scholar
• Kanadia, R. N. et al. A muscleblind knockout model for myotonic dystrophy. Science 302, 1978–1980 (2003)
  Article ADS CAS PubMed Google Scholar
• Wheeler, T. M. et al. Reversal of RNA dominance by displacement of protein sequestered on triplet repeat RNA. Science 325, 336–339 (2009)
  Article ADS CAS PubMed PubMed Central Google Scholar
• Hasselblatt, P., Hockenjos, B., Thoma, C., Blum, H. E. & Offensperger, W. B. Translation of stable hepadnaviral mRNA cleavage fragments induced by the action of phosphorothioate-modified antisense oligodeoxynucleotides. Nucleic Acids Res. 33, 114–125 (2005)
  Article CAS PubMed PubMed Central Google Scholar
• Napierala, M. & Krzyzosiak, W. J. CUG repeats present in myotonin kinase RNA form metastable “slippery” hairpins. J. Biol. Chem. 272, 31079–31085 (1997)
  Article CAS PubMed Google Scholar
• Miller, J. W. et al. Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy. EMBO J. 19, 4439–4448 (2000)
  Article CAS PubMed PubMed Central Google Scholar
• Mankodi, A. et al. Expanded CUG repeats trigger aberrant splicing of ClC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy. Mol. Cell 10, 35–44 (2002)
  Article CAS PubMed Google Scholar
• Du, H. et al. Aberrant alternative splicing and extracellular matrix gene expression in mouse models of myotonic dystrophy. Nature Struct. Mol. Biol. 17, 187–193 (2010)
  Article CAS Google Scholar
• Alter, J. et al. Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology. Nature Med. 12, 175–177 (2006)
  Article CAS PubMed Google Scholar
• Pontius, B. W. & Berg, P. Rapid assembly and disassembly of complementary DNA strands through an equilibrium intermediate state mediated by A1 hnRNP protein. J. Biol. Chem. 267, 13815–13818 (1992)
  CAS PubMed Google Scholar
• Li, L. B. & Bonini, N. M. Roles of trinucleotide-repeat RNA in neurological disease and degeneration. Trends Neurosci. 33, 292–298 (2010)
  Article CAS PubMed PubMed Central Google Scholar
• DeJesus-Hernandez, M. et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72, 245–256 (2011)
  Article CAS PubMed PubMed Central Google Scholar
• Mulders, S. A. et al. Triplet-repeat oligonucleotide-mediated reversal of RNA toxicity in myotonic dystrophy. Proc. Natl Acad. Sci. USA 106, 13915–13920 (2009)
  Article ADS CAS PubMed PubMed Central Google Scholar
• Lee, J. E., Bennett, C. F. & Cooper, T. A. RNase H-mediated degradation of toxic RNA in myotonic dystrophy type 1. Proc. Natl Acad. Sci. USA 109, 4221–4226 (2012)
  Article ADS CAS PubMed PubMed Central Google Scholar
• Wapinski, O. & Chang, H. Y. Long noncoding RNAs and human disease. Trends Cell Biol. 21, 354–361 (2011)
  Article CAS PubMed Google Scholar
• Cheruvallath, Z. S., Kumar, R. K., Rentel, C., Cole, D. L. & Ravikumar, V. T. Solid phase synthesis of phosphorothioate oligonucleotides utilizing diethyldithiocarbonate disulfide (DDD) as an efficient sulfur transfer reagent. Nucleosides Nucleotides Nucleic Acids 22, 461–468 (2003)
  Article CAS PubMed Google Scholar
• Seznec, H. et al. Transgenic mice carrying large human genomic sequences with expanded CTG repeat mimic closely the DM CTG repeat intergenerational and somatic instability. Hum. Mol. Genet. 9, 1185–1194 (2000)
  Article CAS PubMed Google Scholar
• Nakamori, M., Gourdon, G. & Thornton, C. A. Stabilization of expanded (CTG)*(CAG) repeats by antisense oligonucleotides. Mol. Ther. 19, 2222–2227 (2011)
  Article CAS PubMed PubMed Central Google Scholar
• Seznec, H. et al. Mice transgenic for the human myotonic dystrophy region with expanded CTG repeats display muscular and brain abnormalities. Hum. Mol. Genet. 10, 2717–2726 (2001)
  Article CAS PubMed Google Scholar
• Gomes-Pereira, M. et al. CTG trinucleotide repeat “big jumps”: large expansions, small mice. PLoS Genet. 3, e52 (2007)
  Article PubMed PubMed Central Google Scholar
• Wheeler, T. M., Lueck, J. D., Swanson, M. S., Dirksen, R. T. & Thornton, C. A. Correction of ClC-1 splicing eliminates chloride channelopathy and myotonia in mouse models of myotonic dystrophy. J. Clin. Invest. 117, 3952–3957 (2007)
  CAS PubMed PubMed Central Google Scholar
• Koller, E. et al. Mechanisms of single-stranded phosphorothioate modified antisense oligonucleotide accumulation in hepatocytes. Nucleic Acids Res. 39, 4795–4807 (2011)
  Article ADS CAS PubMed PubMed Central Google Scholar
• Ihaka, R. & Gentleman, R. R. A language for data analysis and graphics. J. Comput. Graph. Stat. 5, 299–314 (1996)
  Google Scholar
• Raychaudhuri, S., Stuart, J. M. & Altman, R. B. Principal components analysis to summarize microarray experiments: application to sporulation time series. Pac. Symp. Biocomput. 2000, 455–466 (2000)
  Google Scholar
• Ringnér, M. What is principal component analysis? Nature Biotechnol. 26, 303–304 (2008)
  Article Google Scholar
• Briguet, A., Courdier-Fruh, I., Foster, M., Meier, T. & Magyar, J. P. Histological parameters for the quantitative assessment of muscular dystrophy in the _mdx_-mouse. Neuromuscul. Disord. 14, 675–682 (2004)
  Article PubMed Google Scholar
• Leeds, J. M., Graham, M. J., Truong, L. & Cummins, L. L. Quantitation of phosphorothioate oligonucleotides in human plasma. Anal. Biochem. 235, 36–43 (1996)
  Article CAS PubMed Google Scholar
• Geary, R. S., Matson, J. & Levin, A. A. A nonradioisotope biomedical assay for intact oligonucleotide and its chain-shortened metabolites used for determination of exposure and elimination half-life of antisense drugs in tissue. Anal. Biochem. 274, 241–248 (1999)
  Article CAS PubMed Google Scholar